Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | DPP4 | P27487 | 1/20 | 0.37 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL80527 | 0.90 | MEN1 (0.47) | LMNAPOLBHTTMEN1KMT2A | |
| SCHEMBL4900598 | 0.90 | MEN1 (0.47) | LMNAPOLBHTTMEN1KMT2A | |
| SCHEMBL125466 | 0.86 | MEN1 (0.44) | LMNAPOLBHTTMEN1KMT2A | |
| SCHEMBL28122751 | 0.86 | L3MBTL1 (0.52) | LMNAPOLBHTTMEN1KMT2A | |
| SCHEMBL18344442 | 0.84 | KDM4E (0.39) | LMNAPOLBHTTMEN1KMT2A | |
| SCHEMBL7518324 | 0.83 | MEN1 (0.41) | LMNAPOLBHTTMEN1KMT2A | |
| SCHEMBL18344281 | 0.82 | SDHB (0.37) | LMNAHTTADORA3ADORA1MAPT | |
| Diphenylamine SCHEMBL391850 | 0.80 | IDH2 (0.47) | POLBHTTMEN1KMT2AL3MBTL1 | |
| SCHEMBL8412982 | 0.80 | NPC1 (0.38) | POLBHTTMEN1KMT2AADORA3 | |
| SCHEMBL125931 | 0.79 | KIF11 (0.45) | LMNAADORA3DPP4ABCG2KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180180993-A1 | NEW TRIAZINE AS PHOTO INITIATORS AND THEIR PREPARATION | COVESTRO DEUTSCHLAND AG (DE) | 2018-06-28 | — | — | US | disclosed |
| EP-3320540-A1 | NEW TRIAZINE AS PHOTO INITIATORS AND THEIR PREPARATION | Covestro Deutschland AG (DE) | 2018-05-16 | — | — | EP | disclosed |
| WO-2016207161-A1 | NEW TRIAZINE AS PHOTO INITIATORS AND THEIR PREPARATION | COVESTRO DEUTSCHLAND AG (DE) | 2016-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180180993-A1 | NEW TRIAZINE AS PHOTO INITIATORS AND THEIR PREPARATION | STUB1, BAZ2A, TIPARP | LMNA 3232/4885POLB 1068/4885HTT 647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.